Related Experiment Videos
Risk of thromboembolism after cerebral venous thrombosis
1Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
Insights
Recurrent thromboembolism after cerebral venous thrombosis (CVT) is common. Patients with coagulopathies or deep venous thrombosis history face higher risks, often linked to inadequate anticoagulant treatment.
Area of Science:
- Neurology
- Vascular Medicine
- Thrombosis Research
Background:
- Cerebral venous thrombosis (CVT) outcomes and recurrence rates are infrequently studied.
- Understanding factors influencing CVT recurrence is crucial for patient management.
Purpose of the Study:
- To assess the frequency of recurrent cerebral or systemic thromboembolism after CVT.
- To identify factors associated with thromboembolic recurrence in CVT patients.
Main Methods:
- Retrospective study of 54 consecutive CVT patients (1985-2002).
- Data collected via chart review and telephone interviews.
- Follow-up duration averaged 3.5 years.
Main Results:
- 1.9% experienced recurrent CVT; 12.9% suffered systemic thromboembolism.
- Recurrent thromboembolism was more frequent in patients with coagulopathies (31%) or deep venous thrombosis history.
- Early recurrence was associated with lack of oral anticoagulant treatment.
Conclusions:
- A significant number of patients experience recurrent thromboembolism after CVT.
- Coagulopathies and prior deep venous thrombosis are risk factors for recurrence.
- Oral anticoagulation may be critical in preventing early recurrent venous thromboembolism.
Abstract:
The outcome of cerebral venous thrombosis (CVT) has been studied infrequently. We assessed the frequency of recurrence of cerebral or systemic thromboembolism and factors influencing recurrence. We performed a retrospective study of consecutive patients with CVT in the period 1985-2002 who were admitted to the University Hospital Gasthuisberg. We performed a chart review and a semi-standardized telephone interview that focused on recurrent CVT or systemic thromboembolism. Fifty-four CVT patients with a mean age of 42 years were followed up for a mean of 3.5 years. Eighty percent were women. Coagulation disorders were found in 17 patients (31%). One patient (1.9%) had recurrent CVT and seven patients (12.9%) suffered systemic thromboembolism after a median of 2.5 months. Patients with recurrent thromboembolism more often had coagulopathies (P = 0.04) or a history of deep venous thrombosis (P = 0.007). Patients with early recurrent venous thromboembolism often were not treated with oral anticoagulants (P < 0.001). It was evident from the above study that a substantial number of patients suffer recurrent thromboembolism after CVT.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology